Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia and poses a significant public health burden. Virtual wards are a novel approach utilising digital solutions to provide hospital-level care remotely; their rollout has become a key priority for the UK National Health Service to expand acute care capacity. We devised and implemented a digitally-enabled AF virtual ward to monitor patients being established onto medical therapy following an AF diagnosis or an AF-related hospitalisation. Patients were onboarded either as outpatients to avoid admission or on discharge after an acute AF hospitalisation. Remote monitoring was undertaken using a clinically validated photoplethysmography-based smartphone app. Over a 1–2 week period, patients performed twice daily measurements of heart rate and rhythm and provided corresponding symptoms. A traffic light system guided frequency of telephone assessments by specialist practitioners. Red flag symptoms or abnormal heart rate parameters prompted an urgent care escalation. We report our experience of the first 73 patients onboarded to the AF virtual ward from October 2022 to June 2023 (mean age 65 years, median 68 years, IQR range 27–101 years; 33 females). Thirty-nine (53%) patients had red flag features requiring care escalation, of whom 9 (23%) were advised to attend ED (emergency department) for urgent assessment, 10 (26%) attended for expedited review and 14 (36%) required medication changes. By 3 months post-monitoring, only 3 patients (4%) had re-attended ED with an arrhythmia-related presentation. Virtual ward patients had an average 3-day shorter inpatient stay (mean duration 4 days) compared with AF patients hospitalised prior to virtual ward implementation (mean duration 7 days). Overall, 22 arrhythmia-related readmissions were prevented via the virtual ward model. In this study, we present a novel implementation of a digitally-enabled virtual ward for the acute management of patients with newly diagnosed or poorly controlled AF. Our pilot data indicate that this model is feasible and is potentially cost-effective. Further longitudinal study is needed to definitively evaluate long-term clinical utility and safety.

This dataset contains electronic health records used to study associations between PFAS occurrence and multimorbidity in a random sample of UNC Healthcare system patients. The dataset contains the medical record number to uniquely identify each individual as well as information on PFAS occurrence at the zip code level, the zip code of residence for each individual, chronic disease diagnoses, patient demographics, and neighborhood socioeconomic information from the 2010 US Census. This dataset is not publicly accessible because: EPA cannot release personally identifiable information regarding living individuals, according to the Privacy Act and the Freedom of Information Act (FOIA). This dataset contains information about human research subjects. Because there is potential to identify individual participants and disclose personal information, either alone or in combination with other datasets, individual level data are not appropriate to post for public access. Restricted access may be granted to authorized persons by contacting the party listed. It can be accessed through the following means: Because this data has PII from electronic health records the data can only be accessed with an approved IRB application. Project analytic code is available at L:/PRIV/EPHD_CRB/Cavin/CARES/Project Analytic Code/Cavin Ward/PFAS Chronic Disease and Multimorbidity. Format: This data is formatted as a R dataframe and associated comma-delimited flat text file. The data has the medical record number to uniquely identify each individual (which also serves as the primary key for the dataset), as well as information on the occurrence of PFAS contamination at the zip code level, socioeconomic data at the census tract level from the 2010 US Census, demographics, and the presence of chronic disease as well as multimorbidity (the presence of two or more chronic diseases). This dataset is associated with the following publication: Ward-Caviness, C., J. Moyer, A. Weaver, R. Devlin, and D. Diazsanchez. Associations between PFAS occurrence and multimorbidity as observed in an electronic health record cohort. Environmental Epidemiology. Wolters Kluwer, Alphen aan den Rijn, NETHERLANDS, 6(4): p e217, (2022).

The average age, BMI, number of oocytes collected, peak estrogen levels, cycle number, cumulative FSH, parity and previous live births were calculated for normally cycling fertile women (control subjects), fertile donor women undergoing GnRH agonist protocol (donor agonist), infertile women undergoing GnRH antagonist protocol (antagonist), infertile women undergoing GnRH agonist protocol who did not become pregnant (agonist non pregnant) and infertile women undergoing GnRH agonist protocol who became pregnant in that cycle (agonist pregnant). Data are presented as mean ± SEM with the range presented in brackets. a is significantly different from b, p<0.05.

*Mean ankle brachial indices were all greater than 1 despite one patient having arterial disease; this was due to this same patient also having diabetes mellitus.

This healthcare dataset, covering 55,500 patient records from 2019 to 2024, provides insights into patient demographics, medical conditions, hospital admissions, and billing trends. The average patient age is 51.54 years, with an equal gender distribution and O+ as the most common blood type. Obesity, Cancer, and Arthritis are the most frequent diagnoses, with Diabetes having the highest total billing amount. Emergency admissions are the most common, and the average billing amount is $25,539.32, ranging from - $2,008.49 (possible data error) to $52,764.28. Visualizations include histograms, pie charts, bar graphs, bubble charts, and treemaps, highlighting trends in admission types, medical conditions, and costs. The data can be used for predictive healthcare analytics, hospital resource planning, insurance cost analysis, and public health insights.

Diabetes Health Indicators Dataset

Overview

This dataset contains 100,000 patient records designed for diabetes risk prediction, analysis, and machine learning applications. The dataset is clean, preprocessed, and ready for use in classification, regression, feature engineering, statistical analysis, and data visualization.

• Rows: 100,000
• Columns: 35+
• File: diabetes_dataset.csv

Dataset Description

The dataset includes patient profiles with features based on demographics, lifestyle habits, family history, and clinical measurements that are well-established indicators of diabetes risk. All data is generated using statistical distributions inspired by real-world medical research, ensuring privacy preservation while reflecting realistic health patterns.

Features

Data Quality

• ✅ Complete: No missing values or duplicates
• ✅ Clean: All values fall within medically realistic ranges
• ✅ Balanced Features: Distribution matches realistic population health patterns
• ✅ Target Distribution: ~20–25% diagnosed cases (balanced for ML classification)

Use Cases

• 🩺 Binary Classification → Predict diagnosed_diabetes (Yes/No)
• 🧮 Multiclass Classification → Predict diabetes_stage
• 📊 Regression → Predict glucose_fasting, hba1c, or diabetes_risk_score
• 🔍 EDA & Visualization → Explore lifestyle and clinical health patterns
• 🧠 Machine Learning → Train ML/DL models for healthcare prediction tasks
• 📈 Statistical Testing → Hypothesis testing on health indicators

PurposeRetinal function beyond foveal vision is not routinely examined in the clinical screening and management of diabetic retinopathy although growing evidence suggests it may precede structural changes. In this study we compare optical coherence tomography (OCT) based macular structure with function measured objectively with the ObjectiveFIELD Analyzer (OFA), and with Matrix perimetry. We did that longitudinally in Type 2 diabetes (T2D) patients with mild Diabetic Macular Oedema (DMO) with good vision and a similar number of T2D patients without DMO, to evaluate changes in retinal function more peripherally over the natural course of retinopathy.MethodsBoth eyes of 16 T2D patients (65.0 ± 10.1, 10 females), 10 with baseline DMO, were followed for up longitudinally for 27 months providing 94 data sets. Vasculopathy was assessed by fundus photography. Retinopathy was graded using to Early Treatment of Diabetic Retinopathy Study (ETDRS) guidelines. Posterior-pole OCT quantified a 64-region/eye thickness grid. Retinal function was measured with 10–2 Matrix perimetry, and the FDA-cleared OFA. Two multifocal pupillographic objective perimetry (mfPOP) variants presented 44 stimuli/eye within either the central 30° or 60° of the visual field, providing sensitivities and delays for each test-region. OCT, Matrix and 30° OFA data were mapped to a common 44 region/eye grid allowing change over time to be compared at the same retinal regions.ResultsIn eyes that presented with DMO at baseline, mean retinal thickness reduced from 237 ± 25 μm to 234.2 ± 26.7 μm, while the initially non-DMO eyes significantly increased their mean thickness from 250.7 ± 24.4 μm to 255.7 ± 20.6 μm (both p<0.05). Eyes that reduced in retinal thickness over time recovered to more normal OFA sensitivities and delays (all p<0.021). Matrix perimetry quantified fewer regions that changed significantly over the 27 months, mostly presenting in the central 8 degrees.ConclusionsChanges in retinal function measured by OFA possibly offer greater power to monitor DMO over time than Matrix perimetry data.

US Healthcare Readmissions and Mortality

Evaluating Hospital Performance

By Health [source]

About this dataset

This dataset contains detailed information about 30-day readmission and mortality rates of U.S. hospitals. It is an essential tool for stakeholders aiming to identify opportunities for improving healthcare quality and performance across the country. Providers benefit by having access to comprehensive data regarding readmission, mortality rate, score, measure start/end dates, compared average to national as well as other pertinent metrics like zip codes, phone numbers and county names. Use this data set to conduct evaluations of how hospitals are meeting industry standards from a quality and outcomes perspective in order to make more informed decisions when designing patient care strategies and policies

More Datasets

For more datasets, click here.

Featured Notebooks

• 🚨 Your notebook can be here! 🚨!

How to use the dataset

This dataset provides data on 30-day readmission and mortality rates of U.S. hospitals, useful in understanding the quality of healthcare being provided. This data can provide insight into the effectiveness of treatments, patient care, and staff performance at different healthcare facilities throughout the country.

In order to use this dataset effectively, it is important to understand each column and how best to interpret them. The ‘Hospital Name’ column displays the name of the facility; ‘Address’ lists a street address for the hospital; ‘City’ indicates its geographic location; ‘State’ specifies a two-letter abbreviation for that state; ‘ZIP Code’ provides each facility's 5 digit zip code address; 'County Name' specifies what county that particular hospital resides in; 'Phone number' lists a phone contact for any given facility ;'Measure Name' identifies which measure is being recorded (for instance: Elective Delivery Before 39 Weeks); 'Score' value reflects an average score based on patient feedback surveys taken over time frame listed under ' Measure Start Date.' Then there are also columns tracking both lower estimates ('Lower Estimate') as well as higher estimates ('Higher Estimate'); these create variability that can be tracked by researchers seeking further answers or formulating future studies on this topic or field.; Lastly there is one more measure oissociated with this set: ' Footnote,' which may highlight any addional important details pertinent to analysis such as numbers outlying National averages etc..

This data set can be used by hospitals, research facilities and other interested parties in providing inciteful information when making decisions about patient care standards throughout America . It can help find patterns about readmitis/mortality along county lines or answer questions about preformance fluctuations between different hospital locations over an extended amount of time. So if you are ever curious about 30 days readmitted within US Hospitals don't hesitate to dive into this insightful dataset!

Research Ideas

• Comparing hospitals on a regional or national basis to measure the quality of care provided for readmission and mortality rates.
• Analyzing the effects of technological advancements such as telemedicine, virtual visits, and AI on readmission and mortality rates at different hospitals.
• Using measures such as Lower Estimate Higher Estimate scores to identify systematic problems in readmissions or mortality rate management at hospitals and informing public health care policy

Acknowledgements

If you use this dataset in your research, please credit the original authors. Data Source

License

License: Dataset copyright by authors - You are free to: - Share - copy and redistribute the material in any medium or format for any purpose, even commercially. - Adapt - remix, transform, and build upon the material for any purpose, even commercially. - You must: - Give appropriate credit - Provide a link to the license, and indicate if changes were made. - ShareAlike - You must distribute your contributions under the same license as the original. - Keep intact - all notices that refer to this license, including copyright notices.

Columns

File: Readmissions_and_Deaths_-_Hospital.csv | Column name | Description | |:-------------------------|:---------------------------------------------------------------------------------------------------| | Hospital Name ...

This is a monthly report on publicly funded community services for children, young people and adults using data from the Community Services Data Set (CSDS) reported in England for November 2017. The CSDS is a patient-level dataset providing information relating to publicly funded community services for children, young people and adults. These services can include district nursing services, school nursing services, health visiting services and occupational therapy services, among others. The data collected includes personal and demographic information, diagnoses including long-term conditions and disabilities and care events plus screening activities. It has been developed to help achieve better outcomes for children, young people and adults. It provides data that will be used to commission services in a way that improves health, reduces inequalities, and supports service improvement and clinical quality. Prior to October 2017, the predecessor Children and Young People's Health Services (CYPHS) Data Set collected data for children and young people aged 0-18. The CSDS superseded the CYPHS data set to allow adult community data to be submitted, expanding the scope of the existing data set by removing the 0-18 age restriction. The structure and content of the CSDS remains the same as the previous CYPHS data set. Further information about the CYPHS and related statistical reports is available from https://digital.nhs.uk/data-and-information/data-collections-and-data-sets/data-sets/children-and-young-people-s-health-services-data-set References to children and young people covers records submitted for 0-18 year olds and references to adults covers records submitted for those aged over 18. Where analysis for both groups have been combined, this is referred to as all patients. These statistics are classified as experimental and should be used with caution. Experimental statistics are new official statistics undergoing evaluation. They are published in order to involve users and stakeholders in their development and as a means to build in quality at an early stage. More information about experimental statistics can be found on the UK Statistics Authority website. We hope this information is helpful and would be grateful if you could spare a couple of minutes to complete a short customer satisfaction survey. Please use this form to provide us with any feedback or suggestions for improving the report. Update 6 April 2018: Please note since the removal of the age restriction to include adult data in CSDS, some of our Data Quality measures may not take into account items intended for children only. We are currently reviewing these measures and will look to reflect this in future reports.

Values are expressed as mean (sd) and ratio.

As of 10/22/2020, this dataset is no longer being updated and has been replaced with a new dataset, which can be accessed here: https://data.ct.gov/Health-and-Human-Services/COVID-19-case-rate-per-100-000-population-and-perc/hree-nys2 This dataset includes the average daily COVID-19 case rate per 100,000 population by town over the last two MMWR weeks (https://wwwn.cdc.gov/nndss/document/MMWR_week_overview.pdf). These counts do not include cases among people residing in congregate settings, such as nursing homes, assisted living facilities, or correctional facilities. This dataset will be updated weekly.

MIMIC-III is a large, freely-available database comprising deidentified health-related data associated with over forty thousand patients who stayed in critical care units of the Beth Israel Deaconess Medical Center between 2001 and 2012. The database includes information such as demographics, vital sign measurements made at the bedside (~1 data point per hour), laboratory test results, procedures, medications, caregiver notes, imaging reports, and mortality (including post-hospital discharge).MIMIC supports a diverse range of analytic studies spanning epidemiology, clinical decision-rule improvement, and electronic tool development. It is notable for three factors: it is freely available to researchers worldwide; it encompasses a diverse and very large population of ICU patients; and it contains highly granular data, including vital signs, laboratory results, and medications.

Differences were not significant for any parameter (all P's>0.05); mean ± SD given.

As of July 2nd, 2024 the COVID-19 Deaths by Population Characteristics Over Time dataset has been retired. This dataset is archived and will no longer update. We will be publishing a cumulative deaths by population characteristics dataset that will update moving forward.

A. SUMMARY This dataset shows San Francisco COVID-19 deaths by population characteristics and by date. This data may not be immediately available for recently reported deaths. Data updates as more information becomes available. Because of this, death totals for previous days may increase or decrease. More recent data is less reliable.

Population characteristics are subgroups, or demographic cross-sections, like age, race, or gender. The City tracks how deaths have been distributed among different subgroups. This information can reveal trends and disparities among groups.

B. HOW THE DATASET IS CREATED As of January 1, 2023, COVID-19 deaths are defined as persons who had COVID-19 listed as a cause of death or a significant condition contributing to their death on their death certificate. This definition is in alignment with the California Department of Public Health and the national https://preparedness.cste.org/wp-content/uploads/2022/12/CSTE-Revised-Classification-of-COVID-19-associated-Deaths.Final_.11.22.22.pdf">Council of State and Territorial Epidemiologists. Death certificates are maintained by the California Department of Public Health.

Data on the population characteristics of COVID-19 deaths are from: *Case reports *Medical records *Electronic lab reports *Death certificates

Data are continually updated to maximize completeness of information and reporting on San Francisco COVID-19 deaths.

To protect resident privacy, we summarize COVID-19 data by only one characteristic at a time. Data are not shown until cumulative citywide deaths reach five or more.

Data notes on each population characteristic type is listed below.

Race/ethnicity * We include all race/ethnicity categories that are collected for COVID-19 cases.

Gender * The City collects information on gender identity using these guidelines.

C. UPDATE PROCESS Updates automatically at 06:30 and 07:30 AM Pacific Time on Wednesday each week.

Dataset will not update on the business day following any federal holiday.

D. HOW TO USE THIS DATASET Population estimates are only available for age groups and race/ethnicity categories. San Francisco population estimates for race/ethnicity and age groups can be found in a view based on the San Francisco Population and Demographic Census dataset. These population estimates are from the 2016-2020 5-year American Community Survey (ACS).

This dataset includes many different types of characteristics. Filter the “Characteristic Type” column to explore a topic area. Then, the “Characteristic Group” column shows each group or category within that topic area and the number of deaths on each date.

New deaths are the count of deaths within that characteristic group on that specific date. Cumulative deaths are the running total of all San Francisco COVID-19 deaths in that characteristic group up to the date listed.

This data may not be immediately available for more recent deaths. Data updates as more information becomes available.

To explore data on the total number of deaths, use the COVID-19 Deaths Over Time dataset.

E. CHANGE LOG

• 9/11/2023 - on this date, we began using an updated definition of a COVID-19 death to align with the California Department of Public Health. This change was applied to COVID-19 deaths retrospectively beginning on 1/1/2023. More information about the recommendation by the Council of State and Territorial Epidemiologists that motivated this change can be found https://preparedness.cste.org/wp-content/uploads/2022/12/CSTE-Revised-Classification-of-COVID-19-associated-Deaths.Final_.11.22.22.pdf">here.
• 6/6/2023 - data on deaths by transmission type have been removed. See section ARCHIVED DATA for more detail.
• 5/16/2023 - data on deaths by sexual orientation, comorbidities, homelessness, and single room occupancy have been removed. See section ARCHIVED DATA for more detail.
• 4/6/2023 - the State implemented system updates to improve the integrity of historical data.
• 1/31/2023 - column “population_estimate” added.
• 3/23/2022 - ‘Native American’ changed to ‘American Indian or Alaska Native’ to align with the census.
• 1/22/2022 - system updates to improve timeliness and accuracy of cases and deaths data were implemented.

About this dataset

Context

The dataset presents the mean household income for each of the five quintiles in Miami-Dade County, FL, as reported by the U.S. Census Bureau. The dataset highlights the variation in mean household income across quintiles, offering valuable insights into income distribution and inequality.

Key observations

• Income disparities: The mean income of the lowest quintile (20% of households with the lowest income) is 13,106, while the mean income for the highest quintile (20% of households with the highest income) is 282,078. This indicates that the top earners earn 22 times compared to the lowest earners.
• *Top 5%: * The mean household income for the wealthiest population (top 5%) is 555,008, which is 196.76% higher compared to the highest quintile, and 4234.76% higher compared to the lowest quintile.

https://i.neilsberg.com/ch/miami-dade-county-fl-mean-household-income-by-quintiles.jpeg" alt="Mean household income by quintiles in Miami-Dade County, FL (in 2022 inflation-adjusted dollars))">

Content

When available, the data consists of estimates from the U.S. Census Bureau American Community Survey (ACS) 2017-2021 5-Year Estimates.

Income Levels:

• Lowest Quintile
• Second Quintile
• Third Quintile
• Fourth Quintile
• Highest Quintile
• Top 5 Percent

Variables / Data Columns

• Income Level: This column showcases the income levels (As mentioned above).
• Mean Household Income: Mean household income, in 2022 inflation-adjusted dollars for the specific income level.

Good to know

Margin of Error

Data in the dataset are based on the estimates and are subject to sampling variability and thus a margin of error. Neilsberg Research recommends using caution when presening these estimates in your research.

Custom data

If you do need custom data for any of your research project, report or presentation, you can contact our research staff at research@neilsberg.com for a feasibility of a custom tabulation on a fee-for-service basis.

Inspiration

Neilsberg Research Team curates, analyze and publishes demographics and economic data from a variety of public and proprietary sources, each of which often includes multiple surveys and programs. The large majority of Neilsberg Research aggregated datasets and insights is made available for free download at https://www.neilsberg.com/research/.

Recommended for further research

This dataset is a part of the main dataset for Miami-Dade County median household income. You can refer the same here

OMOP dataset: Hospital COVID patients: severity, acuity, therapies, outcomes Dataset number 2.0

Coronavirus disease 2019 (COVID-19) was identified in January 2020. Currently, there have been more than 6 million cases & more than 1.5 million deaths worldwide. Some individuals experience severe manifestations of infection, including viral pneumonia, adult respiratory distress syndrome (ARDS) & death. There is a pressing need for tools to stratify patients, to identify those at greatest risk. Acuity scores are composite scores which help identify patients who are more unwell to support & prioritise clinical care. There are no validated acuity scores for COVID-19 & it is unclear whether standard tools are accurate enough to provide this support. This secondary care COVID OMOP dataset contains granular demographic, morbidity, serial acuity and outcome data to inform risk prediction tools in COVID-19.

PIONEER geography The West Midlands (WM) has a population of 5.9 million & includes a diverse ethnic & socio-economic mix. There is a higher than average percentage of minority ethnic groups. WM has a large number of elderly residents but is the youngest population in the UK. Each day >100,000 people are treated in hospital, see their GP or are cared for by the NHS. The West Midlands was one of the hardest hit regions for COVID admissions in both wave 1 & 2.

EHR. University Hospitals Birmingham NHS Foundation Trust (UHB) is one of the largest NHS Trusts in England, providing direct acute services & specialist care across four hospital sites, with 2.2 million patient episodes per year, 2750 beds & 100 ITU beds. UHB runs a fully electronic healthcare record (EHR) (PICS; Birmingham Systems), a shared primary & secondary care record (Your Care Connected) & a patient portal “My Health”. UHB has cared for >5000 COVID admissions to date. This is a subset of data in OMOP format.

Scope: All COVID swab confirmed hospitalised patients to UHB from January – August 2020. The dataset includes highly granular patient demographics & co-morbidities taken from ICD-10 & SNOMED-CT codes. Serial, structured data pertaining to care process (timings, staff grades, specialty review, wards), presenting complaint, acuity, all physiology readings (pulse, blood pressure, respiratory rate, oxygen saturations), all blood results, microbiology, all prescribed & administered treatments (fluids, antibiotics, inotropes, vasopressors, organ support), all outcomes.

Available supplementary data: Health data preceding & following admission event. Matched “non-COVID” controls; ambulance, 111, 999 data, synthetic data. Further OMOP data available as an additional service.

Available supplementary support: Analytics, Model build, validation & refinement; A.I.; Data partner support for ETL (extract, transform & load) process, Clinical expertise, Patient & end-user access, Purchaser access, Regulatory requirements, Data-driven trials, “fast screen” services.

After May 3, 2024, this dataset and webpage will no longer be updated because hospitals are no longer required to report data on COVID-19 hospital admissions, and hospital capacity and occupancy data, to HHS through CDC’s National Healthcare Safety Network. Data voluntarily reported to NHSN after May 1, 2024, will be available starting May 10, 2024, at COVID Data Tracker Hospitalizations. The following dataset provides facility-level data for hospital utilization aggregated on a weekly basis (Sunday to Saturday). These are derived from reports with facility-level granularity across two main sources: (1) HHS TeleTracking, and (2) reporting provided directly to HHS Protect by state/territorial health departments on behalf of their healthcare facilities. The hospital population includes all hospitals registered with Centers for Medicare & Medicaid Services (CMS) as of June 1, 2020. It includes non-CMS hospitals that have reported since July 15, 2020. It does not include psychiatric, rehabilitation, Indian Health Service (IHS) facilities, U.S. Department of Veterans Affairs (VA) facilities, Defense Health Agency (DHA) facilities, and religious non-medical facilities. For a given entry, the term “collection_week” signifies the start of the period that is aggregated. For example, a “collection_week” of 2020-11-15 means the average/sum/coverage of the elements captured from that given facility starting and including Sunday, November 15, 2020, and ending and including reports for Saturday, November 21, 2020. Reported elements include an append of either “_coverage”, “_sum”, or “_avg”. A “_coverage” append denotes how many times the facility reported that element during that collection week. A “_sum” append denotes the sum of the reports provided for that facility for that element during that collection week. A “_avg” append is the average of the reports provided for that facility for that element during that collection week. The file will be updated weekly. No statistical analysis is applied to impute non-response. For averages, calculations are based on the number of values collected for a given hospital in that collection week. Suppression is applied to the file for sums and averages less than four (4). In these cases, the field will be replaced with “-999,999”. A story page was created to display both corrected and raw datasets and can be accessed at this link: https://healthdata.gov/stories/s/nhgk-5gpv This data is preliminary and subject to change as more data become available. Data is available starting on July 31, 2020. Sometimes, reports for a given facility will be provided to both HHS TeleTracking and HHS Protect. When this occurs, to ensure that there are not duplicate reports, deduplication is applied according to prioritization rules within HHS Protect. For influenza fields listed in the file, the current HHS guidance marks these fields as optional. As a result, coverage of these elements are varied. For recent updates to the dataset, scroll to the bottom of the dataset description. On May 3, 2021, the following fields have been added to this data set. hhs_ids previous_day_admission_adult_covid_confirmed_7_day_coverage previous_day_admission_pediatric_covid_confirmed_7_day_coverage previous_day_admission_adult_covid_suspected_7_day_coverage previous_day_admission_pediatric_covid_suspected_7_day_coverage previous_week_personnel_covid_vaccinated_doses_administered_7_day_sum total_personnel_covid_vaccinated_doses_none_7_day_sum total_personnel_covid_vaccinated_doses_one_7_day_sum total_personnel_covid_vaccinated_doses_all_7_day_sum previous_week_patients_covid_vaccinated_doses_one_7_day_sum previous_week_patients_covid_vaccinated_doses_all_

PIONEER: Deeply-phenotyped hospital COVID patients: severity, acuity, therapies, outcomes Dataset number 4.0

Coronavirus disease 2019 (COVID-19) was identified in January 2020. Currently, there have been more than 6 million cases& more than 1.5 million deaths worldwide. Some individuals experience severe manifestations of infection, including viral pneumonia, adult respiratory distress syndrome (ARDS)& death. There is a pressing need for tools to stratify patients, to identify those at greatest risk. Acuity scores are composite scores which help identify patients who are more unwell to support & prioritise clinical care. There are no validated acuity scores for COVID-19 & it is unclear whether standard tools are accurate enough to provide this support. This secondary care COVID dataset contains granular demographic, morbidity, serial acuity and outcome data to inform risk prediction tools in COVID-19.

PIONEER geography The West Midlands (WM) has a population of 5.9 million & includes a diverse ethnic & socio-economic mix. There is a higher than average percentage of minority ethnic groups. WM has a large number of elderly residents but is the youngest population in the UK. Each day >100,000 people are treated in hospital, see their GP or are cared for by the NHS. The West Midlands was one of the hardest hit regions for COVID admissions in both wave 1 & 2.

EHR. University Hospitals Birmingham NHS Foundation Trust (UHB) is one of the largest NHS Trusts in England, providing direct acute services & specialist care across four hospital sites, with 2.2 million patient episodes per year, 2750 beds & 100 ITU beds. UHB runs a fully electronic healthcare record (EHR) (PICS; Birmingham Systems), a shared primary & secondary care record (Your Care Connected) & a patient portal “My Health”. UHB has cared for >5000 COVID admissions to date.

Scope: All COVID swab confirmed hospitalised patients to UHB from January – May 2020. The dataset includes highly granular patient demographics & co-morbidities taken from ICD-10 & SNOMED-CT codes but also primary care records& clinic letters. Serial, structured data pertaining to care process (timings, staff grades, specialty review, wards), presenting complaint, acuity, all physiology readings (pulse, blood pressure, respiratory rate, oxygen saturations), all blood results, microbiology, all prescribed & administered treatments (fluids, antibiotics, inotropes, vasopressors, organ support), all outcomes. Linked images available (radiographs, CT, MRI, ultrasound).

Available supplementary data: Health data preceding & following admission event. Matched “non-COVID” controls; ambulance, 111, 999 data, synthetic data.

Available supplementary support: Analytics, Model build, validation & refinement; A.I.; Data partner support for ETL (extract, transform & load) process, Clinical expertise, Patient & end-user access, Purchaser access, Regulatory requirements, Data-driven trials, “fast screen” services.

Life Expectancy of the World Population

The dataset from Worldometer provides a ranked list of countries based on life expectancy at birth, which represents the average number of years a newborn is expected to live under current mortality rates. It includes global, regional, and country-specific life expectancy figures, with separate data for males and females. The dataset highlights disparities in longevity across nations, with countries like Hong Kong, Japan, and South Korea having the highest life expectancies. This data serves as a key indicator of public health, quality of life, and healthcare effectiveness, offering valuable insights for policymakers, researchers, and global health organizations.

Data Analysis & Machine Learning Approaches for Life Expectancy Data

Data Analysis Approaches Life expectancy data can be analyzed using descriptive statistics (mean, variance, distribution) and correlation analysis to identify relationships with factors like GDP, healthcare, and education. Time series analysis helps track longevity trends over time, while clustering techniques (e.g., K-Means) group countries with similar patterns. Additionally, geospatial analysis can visualize regional disparities in life expectancy.

Machine Learning Models For prediction, linear and multiple regression models estimate life expectancy based on socioeconomic indicators, while polynomial regression captures non-linear trends. Decision trees and Random Forests classify countries into high- and low-life expectancy groups. Deep learning techniques like neural networks (ANNs) can model complex relationships, while LSTMs are useful for time-series forecasting.

For pattern detection, K-Means clustering groups countries based on life expectancy trends, and DBSCAN identifies anomalies. Principal Component Analysis (PCA) helps in feature selection, improving model efficiency. These methods provide insights into longevity trends, helping policymakers and researchers improve public health strategies.

Life expectancy at birth. Data based on the latest United Nations Population Division estimates.

Source: https://www.worldometers.info/demographics/life-expectancy/#countries-ranked-by-life-expectancy

About this dataset

Context

The dataset presents the mean household income for each of the five quintiles in Gold Bar, WA, as reported by the U.S. Census Bureau. The dataset highlights the variation in mean household income across quintiles, offering valuable insights into income distribution and inequality.

Key observations

• Income disparities: The mean income of the lowest quintile (20% of households with the lowest income) is 26,663, while the mean income for the highest quintile (20% of households with the highest income) is 174,051. This indicates that the top earners earn 7 times compared to the lowest earners.
• *Top 5%: * The mean household income for the wealthiest population (top 5%) is 207,743, which is 119.36% higher compared to the highest quintile, and 779.14% higher compared to the lowest quintile.

Content

When available, the data consists of estimates from the U.S. Census Bureau American Community Survey (ACS) 2019-2023 5-Year Estimates.

Income Levels:

• Lowest Quintile
• Second Quintile
• Third Quintile
• Fourth Quintile
• Highest Quintile
• Top 5 Percent

Variables / Data Columns

• Income Level: This column showcases the income levels (As mentioned above).
• Mean Household Income: Mean household income, in 2023 inflation-adjusted dollars for the specific income level.

Good to know

Margin of Error

Data in the dataset are based on the estimates and are subject to sampling variability and thus a margin of error. Neilsberg Research recommends using caution when presening these estimates in your research.

Custom data

If you do need custom data for any of your research project, report or presentation, you can contact our research staff at research@neilsberg.com for a feasibility of a custom tabulation on a fee-for-service basis.

Inspiration

Neilsberg Research Team curates, analyze and publishes demographics and economic data from a variety of public and proprietary sources, each of which often includes multiple surveys and programs. The large majority of Neilsberg Research aggregated datasets and insights is made available for free download at https://www.neilsberg.com/research/.

Recommended for further research

This dataset is a part of the main dataset for Gold Bar median household income. You can refer the same here